Zobrazeno 1 - 10
of 1 267
pro vyhledávání: '"Benz, EJ Jr"'
Autor:
Pohl SA; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Nelson BA; Dana-Farber/Harvard Cancer Center Faith Based Cancer Disparities Network, Boston, Massachusetts, USA., Patwary TR; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Amanuel S; Columbia University Mailman School of Public Health, New York, New York, USA., Benz EJ Jr; Dana-Farber Cancer Center, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Lathan CS; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Publikováno v:
CA: a cancer journal for clinicians [CA Cancer J Clin] 2024 Jul-Aug; Vol. 74 (4), pp. 383-396. Date of Electronic Publication: 2024 May 04.
Autor:
Benz EJ Jr; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Silberstein LE; Department of Pediatrics, Center for Joint Transfusion Medicine, Boston Children's Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Panepinto J; Division of Blood Diseases and Blood Resources, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Publikováno v:
Blood [Blood] 2024 Mar 14; Vol. 143 (11), pp. 967-970.
Autor:
Benz EJ Jr; Dana Farber Cancer Institute, Dana Farber/Harvard Cancer Center, Harvard Medical School, Room D 1644a, Dana Building, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: edward_benz@dfci.harvard.edu.
Publikováno v:
Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2023 Apr; Vol. 37 (2), pp. 245-259.
Autor:
Benz EJ Jr; Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Room D1644a, Dana Building, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: edward_benz@dfci.harvard.edu.
Publikováno v:
Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2023 Apr; Vol. 37 (2), pp. xvii-xxi.
Autor:
Benz EJ Jr; Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Boston, MA 02215, USA. Electronic address: edward_benz@dfci.harvard.edu., Sankaran VG; Boston Children's Hospital, 1 Blackfan Street, Karp Family Research Building, Room 7211, Boston, MA 02115, USA. Electronic address: sankaran@broadinstitute.org.
Publikováno v:
Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2023 Apr; Vol. 37 (2), pp. xiii-xv.
Autor:
Huang SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: shu-ching_huang@dfci.harvard.edu., Vu LV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Yu FH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Nguyen DT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Benz EJ Jr; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA; Department of Pediatrics and Genetics, Harvard Medical School, Boston, Massachusetts, USA; Leukemia Program, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, USA.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2021 Sep; Vol. 297 (3), pp. 101051. Date of Electronic Publication: 2021 Aug 06.
Autor:
Schilsky RL; From the American Society of Clinical Oncology, Alexandria, VA (R.L.S.); the Health and Medicine Division, National Academies of Science, Engineering, and Medicine, Washington, DC (S.N.); the University of Chicago Comprehensive Cancer Center, Chicago (M.M.L.B.); and the Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital, and Boston Children's Hospital - all in Boston (E.J.B.)., Nass S; From the American Society of Clinical Oncology, Alexandria, VA (R.L.S.); the Health and Medicine Division, National Academies of Science, Engineering, and Medicine, Washington, DC (S.N.); the University of Chicago Comprehensive Cancer Center, Chicago (M.M.L.B.); and the Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital, and Boston Children's Hospital - all in Boston (E.J.B.)., Le Beau MM; From the American Society of Clinical Oncology, Alexandria, VA (R.L.S.); the Health and Medicine Division, National Academies of Science, Engineering, and Medicine, Washington, DC (S.N.); the University of Chicago Comprehensive Cancer Center, Chicago (M.M.L.B.); and the Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital, and Boston Children's Hospital - all in Boston (E.J.B.)., Benz EJ Jr; From the American Society of Clinical Oncology, Alexandria, VA (R.L.S.); the Health and Medicine Division, National Academies of Science, Engineering, and Medicine, Washington, DC (S.N.); the University of Chicago Comprehensive Cancer Center, Chicago (M.M.L.B.); and the Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital, and Boston Children's Hospital - all in Boston (E.J.B.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2020 Sep 03; Vol. 383 (10), pp. 897-900.
Autor:
Huang SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115; Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115. Electronic address: shu-ching_huang@dfci.harvard.edu., Liang JY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115., Vu LV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115., Yu FH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115., Ou AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115., Ou JP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115., Zhang HS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115., Burnett KM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115., Benz EJ Jr; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115; Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115; Department of Pediatrics and Genetics, Harvard Medical School, Boston, Massachusetts 02115; Dana-Farber/Harvard Cancer Center, Boston, Massachusetts 02115.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2020 Jan 03; Vol. 295 (1), pp. 191-211. Date of Electronic Publication: 2019 Nov 27.
Autor:
Benz EJ Jr; Dana-Farber Cancer Institute, Boston, Massachusetts., Mondoro TH; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Gibbons GH; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Publikováno v:
JAMA [JAMA] 2019 Sep 10; Vol. 322 (10), pp. 921-922.
Advancing the Science of Healthcare Service Delivery: The NHLBI Corporate Healthcare Leaders' Panel.
Autor:
Sampson UKA; Micelle BioPharma, Inc., Nashville, TN, USA. Electronic address: usampson@micellebio.com., McGlynn EA; Center for Effectiveness and Safety Research, Kaiser Permanente, Pasadena, CA, USA., Perlin JB; Hospital Corporation of America, Nashville, TN, USA., Frisse ME; Department of Biomedical informatics, Vanderbilt University School of Medicine, Nashville, TN, USA., Arnold SB; Agency for Healthcare Research and Quality, Rockville, MD, USA., Benz EJ Jr; Dana Farber Cancer Institute, Boston, MA, USA., Brennan T; CVS Health, Woonsocket, RI, USA., Briss P; National Center for Chronic Disease Prevention, Centers for Disease Control, Atlanta, GA, USA., Beeuwkes Buntin MJ; Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN, USA., Khosla S; Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, USA., King RG; BioAccel, Phoenix, AZ, USA., Kuntz R; Medtronic, Inc., Minneapolis, MN, USA., Leider H; Walgreens Boots Alliance, Inc., Deerfield, IL, USA., Ling SM; Centers for Medicare and Medicaid Services, Baltimore, MD, USA., Macrae J; Health Services Research Administration, Rockville, MD, USA., Murray R; Merck and Co., Inc., North Wales, PA, USA., Thrailkill E; AMSURG, Nashville, TN, USA., Wager C; Central Office, Pfizer, New York, NY, USA., Witchey D; Healthcare Leadership Council, Washington, DC, USA., Jacobson HR; Tristar Health Partners, Nashville, TN, USA.
Publikováno v:
Global heart [Glob Heart] 2018 Dec; Vol. 13 (4), pp. 339-345. Date of Electronic Publication: 2018 Oct 06.